GeneFerm monthly revenue
GeneFerm
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0.1B | +50.5% | +22.8% | NT$0.3B |
| May 2026 | Jun 17, 2026 | NT$0B | -8.8% | -8.9% | NT$0.3B |
| Apr 2026 | May 17, 2026 | NT$0.1B | -2.5% | -12.6% | NT$0.2B |
| Mar 2026 | Apr 17, 2026 | NT$0.1B | +14.6% | -12.9% | NT$0.2B |
| Feb 2026 | Mar 17, 2026 | NT$0B | -15.4% | +2.7% | NT$0.1B |
| Jan 2026 | — | NT$0.1B | — | -10.8% | NT$0.1B |
| Dec 2025 | — | NT$0.1B | — | +11.6% | NT$0.7B |
| Nov 2025 | — | NT$0.1B | — | +19.7% | NT$0.6B |
| Oct 2025 | — | NT$0.1B | — | +12.4% | NT$0.6B |
| Sep 2025 | — | NT$0.1B | — | +6.4% | NT$0.5B |
| Aug 2025 | — | NT$0.1B | — | +56.6% | NT$0.4B |
| Jul 2025 | — | NT$0B | — | +18.2% | NT$0.4B |
| Jun 2025 | — | NT$0.1B | — | +66.5% | NT$0.3B |
| May 2025 | — | NT$0.1B | — | +55.3% | NT$0.3B |
| Apr 2025 | — | NT$0.1B | — | +22.1% | NT$0.2B |
| Mar 2025 | — | NT$0.1B | — | +76.2% | NT$0.2B |
| Feb 2025 | — | NT$0B | — | +35.6% | NT$0.1B |
| Jan 2025 | — | NT$0.1B | — | +19.8% | NT$0.1B |
| Dec 2024 | — | NT$0.1B | — | -5.8% | NT$0.5B |
| Nov 2024 | — | NT$0B | — | -24.0% | NT$0.5B |
| Oct 2024 | — | NT$0.1B | — | -15.4% | NT$0.4B |
| Sep 2024 | — | NT$0.1B | — | -7.7% | NT$0.4B |
| Aug 2024 | — | NT$0B | — | -38.6% | NT$0.3B |
| Jul 2024 | — | NT$0B | — | -45.9% | NT$0.3B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-29. Source: Taiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.